A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.
Clinical trial NCT05016323 · COMPLETED
Trial details
- NCT number
- NCT05016323
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-09
- Primary completion
- 2024-06-09
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.